SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-002434
Filing Date
2024-01-05
Accepted
2024-01-05 16:00:12
Documents
14
Period of Report
2024-01-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-20240103.htm   iXBRL 8-K 57898
2 EX-3.1 onct-ex3_1.htm EX-3.1 15220
  Complete submission text file 0000950170-24-002434.txt   228383

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onct-20240103.xsd EX-101.SCH 2902
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT onct-20240103_def.xml EX-101.DEF 13901
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onct-20240103_pre.xml EX-101.PRE 13956
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT onct-20240103_lab.xml EX-101.LAB 18631
8 EXTRACTED XBRL INSTANCE DOCUMENT onct-20240103_htm.xml XML 4896
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 24516124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)